Melanoma vaccine momentum spurs interest, investment.
Fintor
L
L
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D016233:Immunotherapy, Active; D007267:Injections; D007279:Injections, Subcutaneous; D008198:Lymph Nodes; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology; D014481:United States
D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; C116434:Melacine